Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$0.26 - $0.48 $1 - $2
5 Added 5.95%
89 $0
Q3 2023

Nov 13, 2023

BUY
$0.45 - $0.66 $0 - $0
1 Added 1.2%
84 $0
Q2 2023

Aug 15, 2023

BUY
$0.65 - $0.82 $3 - $4
5 Added 6.41%
83 $0
Q1 2023

May 12, 2023

BUY
$0.73 - $1.05 $0 - $1
1 Added 1.3%
78 $0
Q4 2022

Feb 13, 2023

BUY
$0.77 - $22.8 $1 - $45
2 Added 2.67%
77 $0
Q3 2022

Nov 14, 2022

SELL
$0.53 - $22.6 $3 - $135
-6 Reduced 7.41%
75 $0
Q2 2022

Aug 12, 2022

BUY
$0.38 - $0.94 $4 - $12
13 Added 19.12%
81 $0
Q1 2022

May 16, 2022

BUY
$0.89 - $1.26 $7 - $10
8 Added 13.33%
68 $0
Q3 2021

Nov 15, 2021

BUY
$1.87 - $2.57 $26 - $35
14 Added 30.43%
60 $0
Q1 2021

May 13, 2021

BUY
$2.66 - $4.23 $2 - $4
1 Added 2.22%
46 $0
Q4 2020

Feb 09, 2021

BUY
$3.0 - $6.0 $135 - $270
45 New
45 $0

Others Institutions Holding TTNP

# of Institutions
1
Shares Held
23
Call Options Held
0
Put Options Held
0

About TITAN PHARMACEUTICALS INC


  • Ticker TTNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,629,200
  • Market Cap $49.4M
  • Description
  • Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...
More about TTNP
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.